Cascadian receives pediatric waiver in Europe for breast cancer candidate tucatinib; shares ahead 4%

KeepHealthCare.ORG – Cascadian receives pediatric waiver in Europe for breast cancer candidate tucatinib; shares ahead 4% The European Medicines Agency (EMA) grants a product-specific pediatric waiver to Cascadian Therapeutics (CASC Continue reading